Literature DB >> 30778619

Protective effect of salvianolic acid B against oxidative injury associated with cystine stone formation.

Zhang Yifan1, Xu Luwei1, Liang Kai1, Zhou Liuhua1, Ge Yuzheng1, Jia Ruipeng2.   

Abstract

The aim of this study was to investigate the role of oxidative stress in cystine crystal formation and whether salvianolic acid B, a natural antioxidant, could prevent cystine-mediated oxidative injury in vivo and in vitro. The levels of oxidative stress and antioxidase activity in cystine stone patients were assessed. Then, the oxidative stress exerted by cystine on human kidney-2 (HK-2) cell viability and biochemical parameters including antioxidase activity and antioxidant protein expression were evaluated, and the protective action of salvianolic acid B was also examined. Finally, salvianolic acid B was tested to determine whether it could prevent or reduce renal crystal formation in Slc7a9 knockout mice. The activity levels of superoxide dismutase (SOD) and glutathione peroxidase (GPx) were decreased, and the amount of malondialdehyde (MDA) was increased in patients with cystine stones compared with people without cystine stones (p < 0.05). Significant reductions in cell viability, antioxidase activity and antioxidant protein expression levels were found in the cystine group compared with controls. However, such oxidative injuries were prevented by salvianolic acid B. In the animal study, loose crystals with white spots were seen in the renal parenchyma, bilateral renal pelvis and bladders in the Slc7a9 knockout group. In contrast, no renal crystals were seen in the control group, and markedly fewer crystals with significantly higher antioxidase activity and diminished oxidative stress were detected in the salvianolic acid B group. Cystine cytotoxicity in vitro and cystine stone formation in vivo were associated with oxidative stress, and salvianolic acid B could protect against cystine stone-induced injury.

Entities:  

Keywords:  Oxidative injury; Salvianolic acid B; Urolithiasis, cystine stones

Mesh:

Substances:

Year:  2019        PMID: 30778619     DOI: 10.1007/s00240-019-01114-4

Source DB:  PubMed          Journal:  Urolithiasis        ISSN: 2194-7228            Impact factor:   3.436


  28 in total

1.  Vitamin C supplementation and kidney stone risk.

Authors:  Juliet M Pullar; Anitra C Carr; Margreet C M Vissers
Journal:  N Z Med J       Date:  2013-10-18

2.  Pediatric urolithiasis: metabolic risk factors and follow-up results in a Turkish region with endemic stone disease.

Authors:  Ahmet Midhat Elmacı; Aydın Ece; Fatih Akın
Journal:  Urolithiasis       Date:  2014-07-15       Impact factor: 3.436

3.  Durability of the medical management of cystinuria.

Authors:  Paul K Pietrow; Brian K Auge; Alon Z Weizer; Fernando C Delvecchio; Ari D Silverstein; Barbara Mathias; David M Albala; Glenn M Preminger
Journal:  J Urol       Date:  2003-01       Impact factor: 7.450

4.  Cystone® for 1 year did not change urine chemistry or decrease stone burden in cystine stone formers.

Authors:  Stephen B Erickson; Terri J Vrtiska; Vincent J Canzanello; John C Lieske
Journal:  Urol Res       Date:  2010-12-16

Review 5.  Cystinuria in childhood and adolescence: recommendations for diagnosis, treatment, and follow-up.

Authors:  Thomas Knoll; Antonia Zöllner; Gunnar Wendt-Nordahl; Maurice Stephan Michel; Peter Alken
Journal:  Pediatr Nephrol       Date:  2004-11-25       Impact factor: 3.714

6.  Stone clustering of patients with cystine urinary stone formation.

Authors:  Rajveer S Purohit; Marshall L Stoller
Journal:  Urology       Date:  2004-04       Impact factor: 2.649

7.  Sulfur amino acid metabolism in cystinuria: a biochemical and clinical study of patients.

Authors:  J Mårtensson; T Denneberg; A Lindell; O Textorius
Journal:  Kidney Int       Date:  1990-01       Impact factor: 10.612

8.  Combination of chlorogenic acid and salvianolic acid B protects against polychlorinated biphenyls-induced oxidative stress through Nrf2.

Authors:  Lijun Chen; Yuan Li; Wenqin Yin; Wenqi Shan; Jinfeng Dai; Ye Yang; Lei Li
Journal:  Environ Toxicol Pharmacol       Date:  2016-08-03       Impact factor: 4.860

9.  High Sodium-Induced Oxidative Stress and Poor Anticrystallization Defense Aggravate Calcium Oxalate Crystal Formation in Rat Hyperoxaluric Kidneys.

Authors:  Ho-Shiang Huang; Ming-Chieh Ma
Journal:  PLoS One       Date:  2015-08-04       Impact factor: 3.240

10.  Treating the cystine stone former presents a singular clinical challenge.

Authors:  Thomas Chi; Eric Taylor; Marshall L Stoller
Journal:  Transl Androl Urol       Date:  2014-09
View more
  1 in total

1.  Exploring the mechanisms underlying the therapeutic effect of Salvia miltiorrhiza in diabetic nephropathy using network pharmacology and molecular docking.

Authors:  Lili Zhang; Lin Han; Xinmiao Wang; Yu Wei; Jinghui Zheng; Linhua Zhao; Xiaolin Tong
Journal:  Biosci Rep       Date:  2021-06-25       Impact factor: 3.840

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.